NCT06040489View on ClinicalTrials.gov

Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 22, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2026

Conditions
Leishmaniasis; BrazilianLeishmaniasis, Mucocutaneous
Interventions
DRUG

Miltefosine 50mg

Oral Miltefosine 50mg bid

DRUG

Pentoxifylline 400mg

Oral Pentoxifylline 400mg tid

DRUG

Liposomal Amphotericin B

Intravenous 25 to 40mg/kg

Trial Locations (1)

70840-901

RECRUITING

Hospital Universitario de Brasilia, Brasília

All Listed Sponsors
lead

University of Brasilia

OTHER